MAPT and Alzheimer disease: Alzheimer's disease (AD) is a neurodegenerative disease of the central nervous system (CNS), characterized by β-amyloid (Aβ) protein deposition, abnormal phosphorylation of the Tau protein, synaptic dysfunction, and neuroinflammation [1].